Recurrent uveitic macular edema managed with intravitreal faricimab injection
The findings of this case hint towards the potential simultaneous effect of angiopoietin-2 blockade along with vascular endothelia growth factor A inhibition by faricimab in managing treatment-resistant UME. Nonetheless, more studies focusing on the role of intravitreal faricimab in UME are required.
Authors
- Negin Yavari (ORCID: https://orcid.org/0000-0002-9914-2935)
- Christopher Or
- Azadeh Mobasserian
- Quan Dong Nguyen (ORCID: https://orcid.org/0000-0002-6024-8441)
- Khiem S. Nguyen
- Dalia El Feky
- Frances Andrea Añover
Institutions
- Stanford University (US)
Publication Details
- Journal
- Journal of Ophthalmic Inflammation and Infection
- Published
- 2025-03-13
- DOI
- https://doi.org/10.1186/s12348-025-00478-6
- Primary Topic
- Ocular Diseases and Behçet’s Syndrome
- Type
- article
- Field-Weighted Citation Impact
- 0.00